Related Experiment Video
Updated: Jul 29, 2026

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
Published on: March 10, 2023
Comparison of M-TAPA and EOIB to TAP Block in Laparoscopic Cholecystectomy: A Single-Blind Randomized Controlled
Hideki Matsuura1, Yuki Terada, Nobuhiro Tanaka
1Department of Anesthesiology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan. hmatsura0610@gmail.com, hmatsura0610@naramed-u.ac.jp.
Objective:
Laparoscopic cholecystectomy (LC) is one of the most common abdominal surgeries, requiring perioperative pain management for early recovery. Modified thoracoabdominal nerves block through perichondral approach (M-TAPA) and external oblique intercostal block (EOIB) have been reported to be effective in achieving analgesia for upper abdominal surgery. However, the efficacy of M-TAPA and EOIB in LC is still limited. We prospectively evaluated the efficacy of M-TAPA and EOIB as alternatives to the transversus abdominis plane (TAP) block.
Methods:
Fifty patients were randomly assigned to one of three groups: TAP, M-TAPA, or EOIB. The primary outcome was the static pain score at 12 hours postoperatively. The secondary outcomes were postoperative pain scores, rescue narcotic use, time spent on nerve block, presence of complications, and postoperative Quality of Recovery-15 scores.
Results:
Forty-one patients were included in this study. No significant difference in static Numeric Rating Scale score at 12 h postoperatively was found between the TAP and M-TAPA (p = 0.55) or EOIB (p = 0.071). The nerve block duration was shorter in the M-TAPA group (p = 0.011).
Conclusion:
Compared with TAP block, neither M-TAPA nor EOIB showed significant differences in static pain assessment at 12 h after surgery in LC.
More Related Videos
05:36Laparoscopic Common Bile Duct Exploration Followed by Primary Suture Using a Modified Bile Duct Incision
Published on: May 2, 2025
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025